These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9111422)

  • 1. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Sbarbati S; Tombolini V; Mandelli F; D'Arcangelo E; Biagini C
    Ann Hematol; 1997 Mar; 74(3):103-10. PubMed ID: 9111422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
    Tura S; Fiacchini M; Zinzani PL; Brusamolino E; Gobbi PG
    J Clin Oncol; 1993 May; 11(5):925-30. PubMed ID: 8487056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
    Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
    J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
    Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
    J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V; Jais JP; Colonna P; Andrieu JM
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
    Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Van den Berghe H
    Cancer Genet Cytogenet; 1988 Dec; 36(2):165-72. PubMed ID: 3203304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukaemia in patients treated for Hodgkin's disease.
    Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
    Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    Aisenberg AC
    Am J Med; 1983 Sep; 75(3):449-54. PubMed ID: 6688502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
    J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
    Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):197-210. PubMed ID: 6368491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience.
    Henry-Amar M; Pellae-Cosset B; Bayle-Weisgerber C; Hayat M; Cosset JM; Carde P; Tubiana M
    Recent Results Cancer Res; 1989; 117():270-83. PubMed ID: 2602650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
    Henkelmann GC; Hagemeister FB; Fuller LM
    J Clin Oncol; 1988 Aug; 6(8):1293-302. PubMed ID: 3411342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.